Oracle Investment Management as of Dec. 31, 2025
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 22 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 68.5 | $115M | 885k | 130.06 | |
| Ardelyx (ARDX) | 6.5 | $11M | 1.9M | 5.83 | |
| Biohaven (BHVN) | 5.2 | $8.7M | 772k | 11.29 | |
| Teladoc Health Call Call Option | 2.7 | $4.6M | 650k | 7.00 | |
| Novavax Note 5.000%12/1 Call Option (Principal) | 2.4 | $4.0M | 600k | 6.72 | |
| Ardelyx Call Call Option | 2.1 | $3.5M | 600k | 5.83 | |
| Quidel Corp (QDEL) | 2.0 | $3.4M | 118k | 28.56 | |
| Forian Ord (FORA) | 1.7 | $2.9M | 1.4M | 2.12 | |
| Personalis Ord (PSNL) | 1.6 | $2.7M | 339k | 7.96 | |
| Biohaven Call Call Option | 1.6 | $2.6M | 233k | 11.29 | |
| Teladoc (TDOC) | 1.5 | $2.5M | 354k | 7.00 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.9 | $1.5M | 265k | 5.50 | |
| Cava Group Ord (CAVA) | 0.6 | $1.0M | 17k | 58.69 | |
| Edgewise Therapeutics (EWTX) | 0.6 | $952k | 38k | 24.82 | |
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $932k | 100k | 9.32 | |
| Pfizer Call Call Option | 0.4 | $623k | 25k | 24.90 | |
| Ark Etf Tr Genomic Rev Etf (ARKG) | 0.3 | $565k | 20k | 28.97 | |
| Sangamo Biosciences (SGMO) | 0.3 | $435k | 1.0M | 0.42 | |
| Biogen Idec (BIIB) | 0.3 | $425k | 2.4k | 175.99 | |
| Tempus Ai Cl A (TEM) | 0.2 | $384k | 6.5k | 59.05 | |
| Tesla Motors (TSLA) | 0.1 | $225k | 500.00 | 449.72 | |
| Hertz Global Hldgs Com New (HTZ) | 0.0 | $77k | 15k | 5.14 |
